Skip to main content

Carotid Angioplasty and Stenting (CAS)

  • Chapter
  • First Online:
Book cover Interventional Radiology for Medical Students

Abstract

  • Ten percent of acute ischemic strokes (AIS) are due to severe carotid artery stenosis, making carotid revascularization one of the most important therapeutic managements in ischemic stroke.

  • Older guidelines had reserved carotid artery stenting (CAS) for severe stenosis in symptomatic patients considered high risk for carotid endarterectomy (CEA).

  • These guidelines were based on multiple previous trials including the North American Symptomatic Carotid Endarterectomy Trial (NASCET) and European Carotid Surgery Trial (ECST) that provided evidence of the superiority of CEA as the best medical therapy for symptomatic patients.

  • However, the recent long-term results from the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST), with over 10-years comprehensive follow-up, did not find a significant difference between patients who underwent stenting versus those who underwent endarterectomy with respect to the risk of peri-procedural stroke, myocardial infarction, or death, as well as subsequent ipsilateral stroke. Also, the rate of post-procedural ipsilateral stroke also did not differ between the two groups.

  • This equipoise likely benefitted from increasing refinement in CAS device technology and improving techniques over the past decade.

  • The jury is still out for asymptomatic patients, as the current evidence for this group of patients, based on Asymptomatic Carotid Atherosclerosis Study (ACAS) and the Asymptomatic Carotid Surgery Trial (ACST), is of CEA superiority in patients with more than 60% carotid stenosis, with approximately 5.5% reduction in 5-year stroke risk over CAS.

  • The most important question about patients with asymptomatic significant carotid stenosis, recently defined as more than 70%, is whether medical treatment alone is sufficient or inferior to combined medical therapy and surgical intervention, and if inferior whether there is equipoise between CAS and CEA.

  • This is the question that the CREST-2 study is trying to answer by 2020.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 149.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  1. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998;339(20):1415–25.

    Article  CAS  PubMed  Google Scholar 

  2. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2011;57(8):e16–94.

    Article  PubMed  Google Scholar 

  3. Brott TG, Howard G, Roubin GS, Meschia JF, Mackey A, Brooks W, et al. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med. 2016;374(11):1021–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Collaborators NASCET. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325(7):445–53.

    Article  Google Scholar 

  5. Enomoto Y, Yoshimura S. Antiplatelet therapy for carotid artery stenting. Interve Neurol. 2013;1(3–4):151–63.

    Google Scholar 

  6. Garg N, Karagiorgos N, Pisimisis GT, Sohal DP, Longo GM, Johanning JM, et al. Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: a systematic review of the current literature. J Endovasc Ther. 2009;16(4):412–27.

    Article  PubMed  Google Scholar 

  7. Group MACSTC. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363(9420):1491–502.

    Article  Google Scholar 

  8. Hobson RW, Howard VJ, Brott TG, Howard G, Roubin GS, Ferguson R. Organizing the carotid revascularization endarterectomy versus stenting trial (crest): national institutes of health, health care financing administration, and industry funding. Curr Control Trials Cardiovasc Med. 2001;2(4):160–4.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hopkins LN, Roubin GS, Chakhtoura EY, Gray WA, Ferguson RD, Katzen BT, et al. The carotid revascularization endarterectomy versus stenting trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis. 2010;19(2):153–62.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Investigators A. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273(18):1421–8.

    Article  Google Scholar 

  11. Lal B, Meschia J, Brott T. CREST-2: guiding treatments for asymptomatic carotid disease. Endovascular Today. 2013:73–6.

    Google Scholar 

  12. Lam RC, Lin SC, DeRubertis B, Hynecek R, Kent KC, Faries PL. The impact of increasing age on anatomic factors affecting carotid angioplasty and stenting. J Vasc Surg. 2007;45(5):875–80.

    Article  PubMed  Google Scholar 

  13. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics—2010 update a report from the American Heart Association. Circulation. 2010;121(7):e46–e215.

    Article  PubMed  Google Scholar 

  14. Macdonald S, Lee R, Williams R, Stansby G. Towards safer carotid artery stenting a scoring system for anatomic suitability. Stroke. 2009;40(5):1698–703.

    Article  PubMed  Google Scholar 

  15. Vogel TR, Dombrovskiy V. Carotid artery stenting in the nation: the influence of hospital and physician volume on outcomes. Vasc Endovasc Surg. 2009;45(2):205.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hamed Asadi MD, PhD, FRANZCR, CCINR, EBIR .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Asadi, H. (2018). Carotid Angioplasty and Stenting (CAS). In: Kok, H., Ryan, E., Asadi, H., Lee, M. (eds) Interventional Radiology for Medical Students. Springer, Cham. https://doi.org/10.1007/978-3-319-53853-2_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-53853-2_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-53852-5

  • Online ISBN: 978-3-319-53853-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics